-

OLO SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Price Adequacy of Olo Inc. (NYSE: OLO) Shareholder Buyout - Does $10.25 Per Share Undervalue OLO Shares?

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is actively investigating the fairness of the recently announced buyout of Olo Inc. (NYSE: OLO) shareholders to determine whether the buyout price undervalues the company's shares. Olo shareholders are strongly encouraged to contact the firm to discuss their legal rights and options with respect to this buyout proposal.

The investigation so far has discovered that the transaction appears to have significant conflicts of interest, thus making the sales process and consideration unfair to the company’s shareholders.

Share

Click here to receive information about your legal rights and options: https://kaskelalaw.com/case/olo-inc/

On July 3, 2025, Olo announced that it had agreed to be acquired by private equity firm Thoma Bravo at a price of $10.25 per share in cash. Following the closing of the transaction, Olo's shareholders will be cashed out of their investment position and the company's shares will no longer be publicly traded.

The investigation so far has discovered that the transaction appears to have significant conflicts of interest, thus making the sales process and consideration unfair to the company’s shareholders. Further, at the time the transaction was announced, at least one stock analyst was maintaining a price target of $11.00 per share for Olo's shares.

Olo shareholders who believe the buyout price is too low are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (888) 715 – 1740, or by clicking on the following link (or by copying and pasting the link into your browser):

https://kaskelalaw.com/case/olo-inc/

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation in contingent litigation. For additional information about Kaskela Law LLC, including the firm's recent notable recoveries for investors, please visit www.kaskelalaw.com.

This communication may constitute attorney advertising in certain jurisdictions.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

Industry:

Kaskela Law LLC

NYSE:OLO
Release Versions
English

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
(skaskela@kaskelalaw.com)
Adrienne Bell, Esq.
(abell@kaskelalaw.com)
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal”) on behalf of the company’s current shareholders. The investigation seeks to determine whether Amneal or the company’s officers and/or directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Amneal shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional infor...

Kaskela Law Firm Announces Investigation of DexCom, Inc. (DXCM) and Encourages Long-Term DXCM Shareholders with Investment Losses to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating DexCom, Inc. (Nasdaq: DXCM) on behalf of the company’s long-term investors. Click here for additional information: https://kaskelalaw.com/case/dexcom-inc/ Recently a securities fraud complaint was filed against DexCom on behalf of investors who purchased shares of the company's stock between January 8, 2024 and September 17, 2025 (the “Wrongdoing Period”). According to the complaint, during th...

Kaskela Law Firm Announces Investigation of Fortrea Holdings Inc. (FTRE) and Encourages Long-Term FTRE Shareholders with Investment Losses to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating Fortrea Holdings Inc. (Nasdaq: FTRE) (“Fortrea”) on behalf of the company’s long-term investors. Click here for additional information: https://kaskelalaw.com/case/fortrea-holdings/ Recently a securities fraud complaint was filed against Fortrea on behalf of certain investors who purchased shares of the company’s stock between July 5, 2023 and February 28, 2025 (the “Wrongdoing Period”). Accor...
Back to Newsroom